Related Experiment Video
Updated: Jul 15, 2026
04:30
Investigating Aortic Valve Calcification via Isolation and Culture of T Lymphocytes using Feeder Cells from Irradiated Buffy Coat
Published on: February 4, 2021
Calcific aortic stenosis: an update
Nalini M Rajamannan1, Robert O Bonow, Shahbudin H Rahimtoola
1Bluhm Cardiovascular Institute, Chicago, IL, USA.
Nature Clinical Practice. Cardiovascular Medicine
|April 26, 2007
Summary
Calcific aortic stenosis, a leading cause of valve replacement, is increasingly linked to a degenerative process similar to vascular atherosclerosis. This shift highlights new therapeutic avenues for this common elderly condition.
Area of Science:
- Cardiology
- Gerontology
- Pathophysiology
Background:
- Calcific aortic stenosis (CAS) is the primary indication for surgical valve replacement in the US and Europe.
- The incidence of CAS is rising due to an aging global population.
- Historically attributed to rheumatic heart disease, CAS is now predominantly linked to degenerative mechanisms.
Purpose of the Study:
- To review the current understanding of calcific aortic stenosis pathophysiology.
- To explore risk factors, cellular mechanisms, and diagnostic approaches.
- To discuss emerging medical therapies for degenerative aortic valve disease.
Main Methods:
- Literature review of recent studies on aortic valve disease.
- Analysis of the shift in etiology from rheumatic to degenerative causes.
- Comparison of CAS pathophysiology with vascular atherosclerosis.
Main Results:
- Evidence suggests CAS shares pathophysiological pathways with vascular atherosclerosis.
- The understanding of CAS has evolved from passive calcification to an active, complex process.
- This evolving understanding opens possibilities for novel therapeutic strategies.
Conclusions:
- Degenerative aortic stenosis is a growing concern in aging populations.
- The disease mechanism is increasingly understood to mirror atherosclerosis.
- Future treatments may target pathways similar to those used for vascular diseases.
Related Concept Videos
01:25Aortic Regurgitation III: Medical Management
Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
01:15Aortic Regurgitation I: Introduction
IntroductionAortic regurgitation is characterized by the backward flow of blood from the aorta into the left ventricle during diastole and arises from the improper closure of the aortic valve. This condition results in left ventricular volume overload and can stem from both acute and chronic etiologies, each contributing uniquely to the disease's progression and symptomatology.Acute and Chronic CausesAcute aortic regurgitation often results from events that suddenly impair the integrity of the...
01:26Mitral Stenosis III: Medical Management
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
01:22Mitral Stenosis I: Introduction
Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
01:22Aortic Regurgitation II: Clinical Features and Diagnostic Tests
Aortic valve regurgitation (AR) occurs when the aortic valve fails to close properly, allowing blood to flow backward from the aorta into the left ventricle. This backflow can result in two distinct clinical presentations: acute and chronic AR, each characterized by its own set of symptoms and physical findings.Acute Aortic RegurgitationAcute AR presents with a sudden onset of severe symptoms. Patients typically experience profound dyspnea (shortness of breath), chest pain, and signs of left...
01:21Aneurysm II: Clinical Manifestations and Diagnostic Studies
Thoracic, aortic arch and abdominal aneurysms are significant vascular conditions that can present with various clinical manifestations and lead to serious complications. Understanding these manifestations and the appropriate diagnostic studies is essential for effective management and treatment.Thoracic Aortic AneurysmsThoracic aortic aneurysms often remain asymptomatic until they reach a size that impinges on adjacent structures. They typically cause deep, diffuse chest pain that radiates to...